Efficacy and Safety of Becotatug Vedotin (MRG003) Combined With Anti-PD1 as Maintenance Therapy for Recurrent and Metastatic Nasopharyngeal Carcinoma
Clinical trial NCT07705243 · RECRUITING
Trial details
- NCT number
- NCT07705243
- Sponsor
- Sun Yat-sen University
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-20
- Primary completion
- 2028-07-20
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.